Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Aug;42(1-2):40-3.
doi: 10.1007/BF02014298.

Inhibition of inflammatory angiogenesis in rats by loco-regional administration of hydrocortisone and protamine

Affiliations

Inhibition of inflammatory angiogenesis in rats by loco-regional administration of hydrocortisone and protamine

D Foschi et al. Agents Actions. 1994 Aug.

Abstract

We have studied the antiangiogenetic effects of hydrocortisone and protamine given intra-arterially. The cornea of male, Sprague-Dawley rats were cauterized with silver nitrate. The following treatments were given: 30 micrograms hydrocortisone topical (t.p.), b.i.d., 50 mg/kg/day intraperitoneally (i.p.) or intra-arterially (i.a.), 10 mg/kg/day protamine i.p. or i.a. Saline was administered to the control groups. In separate experiments we also evaluated the anti-inflammatory effects of hydrocortisone, i.p., on the cauterized corneas. Five days after cauterization, the animals were killed, exsanguinated and India ink was injected to show the network of neovessels. The percentage area of the cornea covered by neovessels was measured morphometrically and evaluated statistically. Hydrocortisone t.p. (-84%), i.a. (-60%) and protamine i.a. (-44%) significantly inhibited angiogenesis in the cauterized cornea. Either drugs, i.p., had any antiangiogenetic effects, but hydrocortisone significantly reduced cell infiltration of the corneas. The results suggest that locoregional administration of antiangiogenetic drugs might be clinically useful.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lab Invest. 1988 Jul;59(1):44-51 - PubMed
    1. J Clin Invest. 1989 Jan;83(1):158-67 - PubMed
    1. Arch Ophthalmol. 1985 Feb;103(2):284-7 - PubMed
    1. Nature. 1990 Dec 6;348(6301):555-7 - PubMed
    1. Endocrinology. 1986 Oct;119(4):1768-75 - PubMed